An antibody (or immunoglobulin) is a glycoprotein produced by the immune system in response to a ‘foreign ... They are classified into primary and secondary based on their binding capability ...

Researchers conducted the IMPROVE trial to evaluate whether a 3-week pause in BTK inhibitor use would improve immunity after COVID-19 booster vaccination without negatively affecting disease control ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO ...

An antigen is any substance that prompts your body to trigger an immune response against it. Antigens include allergens, bacteria and viruses. Antibodies are Y-shaped proteins that the body produces ...

The prespecified primary immunogenicity objectives were to show neutralizing antibody responses that were noninferior to 50-μg mRNA-1273 (on the basis of geometric mean titer ratio and difference ...

The new results are the latest from Wilson's team tracking the antibody response to the COVID-19 vaccines over time. The researchers previously found that after the primary vaccination series the ...

They found that upon primary immunization, participants with pre-existing immunity (those who had previously been infected with the virus) mounted higher antibody responses faster and achieved ...

HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial ... and 12 weeks after vaccination. The primary outcome was fold rise in antibody titers from ...

Researchers led by Imperial have unveiled primary trial ... that an immune response can be harnessed to control HIV, ...